Global Antibody-drug Conjugate Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI260529
  • March 20, 2019
  • Global
  • 90 pages
  • QY Market Research
                                              "The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Antibody-drug Conjugate market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Antibody-drug Conjugate market."
Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugsdesigned as a targeted therapy for the treatment of people with cancer. Unlike chemotherapy, ADCs are intended to target and kill only the cancer cells and spare healthy cells.

The global Antibody-drug Conjugate market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antibody-drug Conjugate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody-drug Conjugate market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Concortis Biotherapeutics
    Celldex Therapeutics
    Synthon Holding BV

Segment by Regions
    North America

Segment by Type

Segment by Application
    Breast Cancer

Table of Contents

Executive Summary
1 Antibody-drug Conjugate Market Overview
    1.1 Product Overview and Scope of Antibody-drug Conjugate
    1.2 Antibody-drug Conjugate Segment by Type
        1.2.1 Global Antibody-drug Conjugate Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Adcetris
        1.2.3 Kadcyla
    1.3 Antibody-drug Conjugate Segment by Application
        1.3.1 Antibody-drug Conjugate Consumption Comparison by Application (2014-2025)
        1.3.2 Breast Cancer
        1.3.3 Lymphoma
    1.4 Global Antibody-drug Conjugate Market by Region
        1.4.1 Global Antibody-drug Conjugate Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Antibody-drug Conjugate Market Size
        1.5.1 Global Antibody-drug Conjugate Revenue (2014-2025)
        1.5.2 Global Antibody-drug Conjugate Production (2014-2025)

2 Global Antibody-drug Conjugate Market Competition by Manufacturers
    2.1 Global Antibody-drug Conjugate Production Market Share by Manufacturers (2014-2019)
    2.2 Global Antibody-drug Conjugate Revenue Share by Manufacturers (2014-2019)
    2.3 Global Antibody-drug Conjugate Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Antibody-drug Conjugate Production Sites, Area Served, Product Types
    2.5 Antibody-drug Conjugate Market Competitive Situation and Trends
        2.5.1 Antibody-drug Conjugate Market Concentration Rate
        2.5.2 Antibody-drug Conjugate Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Antibody-drug Conjugate Production Market Share by Regions
    3.1 Global Antibody-drug Conjugate Production Market Share by Regions
    3.2 Global Antibody-drug Conjugate Revenue Market Share by Regions (2014-2019)
    3.3 Global Antibody-drug Conjugate Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Antibody-drug Conjugate Production
        3.4.1 North America Antibody-drug Conjugate Production Growth Rate (2014-2019)
        3.4.2 North America Antibody-drug Conjugate Production, Revenue, Price and Gross Margin (2014-2019)
    3.5 Europe Antibody-drug Conjugate Production
        3.5.1 Europe Antibody-drug Conjugate Production Growth Rate (2014-2019)
| 

Request a sample

Fill below form to request a sample


Please fill this form to enquire before buying


You can request for discount regarding the report by using below form